Clinical Trials Logo

Clinical Trial Summary

The goal of this study was to evaluate the effects of the fast weight loss on clinic and laboratory inflammation profile, metabolic profile, reactive oxygen species (ROS) and body composition in patients with COVID and Influenza in comorbidity with NCDs. Primary endpoints: Clinic/infectious/inflammation tests for COVID and Influenza; weight loss during 14 days. Secondary endpoints: fasting blood glucose, HbA1c, blood insulin; systolic/diastolic BP; blood lipids; ALT, AST, chest CT-scan.


Clinical Trial Description

Study Design. A 6-week, open, pilot prospective clinical trial with the intention-to-treat principle. Participants: The study enrolled 72 adult people (38 women) aged from 25 to 80 years with moderate-to-severe cases COVID and Influenza in comorbidity with NCDs as T2D, hypertension, and NASH. All patients with the ARDs had in comorbidity with one or more NCDs. All patients refused for pharmacology therapy due to: either previous unsuccessful drug results; or an antimicrobial resistance profile; or drug allergy; or reluctance to take medication; or iatrogenic fear (iatrophobia); or a rich failed experience in drug treatment; and NASH. All the patients were admitted into the out-patient department in 3-5 days after illness onset. The study was carried out in the Republic of Kazakhstan from November, 2020, through July, 2022 at University Medical Center (Astana) and ANADETO medical center. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05635539
Study type Interventional
Source University Medical Center, Kazakhstan
Contact
Status Completed
Phase N/A
Start date August 1, 2020
Completion date July 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT04395430 - A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19 N/A
Completed NCT03250715 - Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure N/A
Completed NCT03501225 - Effects of Ozonated Water on Pain, Swelling, Trismus and Quality of Life in Third Molar Surgery N/A
Terminated NCT03308435 - Effect of TF-TAVR on Emotional Status, Quality of Life, Frailty and Inflammation
Recruiting NCT03864250 - Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy N/A
Completed NCT03351283 - Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure N/A
Completed NCT03757767 - The Fasting Study - Unraveling the Mechanistic Effects of Prolonged Fasting in Humans. N/A
Recruiting NCT05712616 - Role of Strontium Ranelate in Proximal Femur Fragility Fractures. Phase 4
Active, not recruiting NCT03013309 - Raising Healthy Children: A Hybrid Trial of the Family Check-Up 4 Health in Primary Care N/A
Completed NCT03189511 - Effect of Fluvastatin on Brown Fat Activity Phase 4
Recruiting NCT03788876 - Neuromuscular Electrical Stimulation After Lung Transplantation N/A
Completed NCT05622760 - Impact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening N/A
Enrolling by invitation NCT04469816 - AFRI Childhood Obesity Prevention Challenge Area N/A
Completed NCT04958460 - Effect of Probiotics on ADHD Phase 3
Completed NCT03124316 - Testing a Behavioural Approach to Improving Cancer Screening Rates N/A
Recruiting NCT06037603 - Dual-Task Exercise for Mild Traumatic Brain Injury (mTBI) N/A
Completed NCT03037476 - Personalized Health Assessment Related to Medications (Project PHARM) N/A
Completed NCT01149278 - Assessment of Two Levels of Arterial Pressure on Survival in Patients With Septic Shock N/A
Completed NCT05012709 - A Study of Dose-response Relationship and the Evidence Based Multisensory Stimulation Intervention N/A
Recruiting NCT04719221 - Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome Phase 4